Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139
- PMID: 11874883
- PMCID: PMC119965
- DOI: 10.1128/cdli.9.2.383-387.2002
Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139
Abstract
A microplate assay for the detection of bactericidal antibodies to Vibrio cholerae O139 is described. The assay is sensitive, highly reproducible, specific, and convenient to perform. It has been used to demonstrate the induction of serum bactericidal antibodies in Vietnamese recipients of an oral, inactivated, bivalent O1/O139 vaccine, as well as in Bangladeshi patients with O139 disease. In both study groups there was a significant inverse correlation between the preexposure level of antibodies in serum and the magnitude of the subsequent bactericidal response. Although infection generated stronger responses than vaccination, the proportion of responders was similar among individuals with low background titers.
Figures


Similar articles
-
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.mSphere. 2021 Aug 25;6(4):e0011421. doi: 10.1128/mSphere.00114-21. Epub 2021 Jul 7. mSphere. 2021. PMID: 34232076 Free PMC article.
-
Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.Clin Diagn Lab Immunol. 2000 May;7(3):444-50. doi: 10.1128/CDLI.7.3.444-450.2000. Clin Diagn Lab Immunol. 2000. PMID: 10799459 Free PMC article.
-
Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.Vaccine. 1996 Oct;14(15):1459-65. doi: 10.1016/s0264-410x(96)00071-0. Vaccine. 1996. PMID: 8994322 Clinical Trial.
-
Cholera vaccines.Clin Infect Dis. 2000 Aug;31(2):561-5. doi: 10.1086/313951. Epub 2000 Sep 7. Clin Infect Dis. 2000. PMID: 10987721 Review.
-
PaxVax CVD 103-HgR single-dose live oral cholera vaccine.Expert Rev Vaccines. 2017 Mar;16(3):197-213. doi: 10.1080/14760584.2017.1291348. Expert Rev Vaccines. 2017. PMID: 28165831 Review.
Cited by
-
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India.PLoS One. 2008 Jun 4;3(6):e2323. doi: 10.1371/journal.pone.0002323. PLoS One. 2008. PMID: 18523643 Free PMC article. Clinical Trial.
-
A Novel Luminescence-Based Serum Bactericidal Assay for Vibrio cholerae Reduces Assay Variation, Is Time- and Cost-Effective, and Directly Measures Continuous Titer Values.Am J Trop Med Hyg. 2021 Jul 8;105(3):622-626. doi: 10.4269/ajtmh.21-0136. Am J Trop Med Hyg. 2021. PMID: 34237020 Free PMC article.
-
Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.PLoS One. 2014 May 6;9(5):e96499. doi: 10.1371/journal.pone.0096499. eCollection 2014. PLoS One. 2014. PMID: 24800828 Free PMC article. Clinical Trial.
-
Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.J Microbiol. 2017 Dec;55(12):973-978. doi: 10.1007/s12275-017-7478-0. Epub 2017 Dec 7. J Microbiol. 2017. PMID: 29214494
-
Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.Hum Vaccin Immunother. 2017 Oct 3;13(10):2232-2239. doi: 10.1080/21645515.2017.1342908. Hum Vaccin Immunother. 2017. PMID: 28910563 Free PMC article. Clinical Trial.
References
-
- Attridge, S. R. 1991. Oral immunisation with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O antigen: serum bactericidal antibody responses in man in relation to pre-immunisation antibody levels. Vaccine 9:877-882. - PubMed
-
- Cholera Working Group. 1993. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 342:387-390. - PubMed
-
- Coster, T. S., K. P. Killeen, M. K. Waldor, D. T. Beattie, D. R. Spriggs, J. R. Kenner, A. Trofa, J. C. Sadoff, J. J. Mekalanos, and D. N. Taylor. 1995. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345:949-952. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical